A U.S. jury has ordered Japanese drugmaker Takeda Pharmaceutical Co. and its U.S. counterpart, Eli Lilly and Co., to pay $9 billion in punitive damages over a diabetes medicine linked to cancer. The d…
Already an INSIDER? Sign in.
Takeda, Eli Lilly vow to ‘vigorously challenge’ $9 billion ruling against them
